We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

107 hedge funds and large institutions have $37.8M invested in Zomedica Corp. in 2021 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 26

0% more funds holding

Funds holding: 107 → 107 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

39% less capital invested

Capital invested by funds: $61.8M → $37.8M (-$24M)

Holders
107
Holders Change
–
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
32
Reduced
26
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$2.67M
2
GCP
GSA Capital Partners
United Kingdom
+$539K
3
VF
Virtu Financial
New York
+$505K
4
N
Nuveen
North Carolina
+$478K
5
UBS AM
UBS AM
Illinois
+$387K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.43M
2
HF
HRT Financial
New York
-$209K
3
SSA
Schonfeld Strategic Advisors
New York
-$209K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$177K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$176K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
101
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
HF
102
HRT Financial
New York
– -$209K -399,494 Closed
SSA
103
Schonfeld Strategic Advisors
New York
– -$209K -399,217 Closed
Millennium Management
104
Millennium Management
New York
– -$119K -226,649 Closed
AI
105
Atom Investors
Texas
– -$90K -171,126 Closed
SIA
106
SkyView Investment Advisors
New Jersey
– -$22K -41,650 Closed
BRWA
107
B. Riley Wealth Advisors
Florida
– -$13K -23,000 Closed
RIS
108
Retirement Income Solutions
Michigan
– -$11K -21,599 Closed
BCM
109
Bayesian Capital Management
New York
– -$7K -13,000 Closed
HI
110
Harbour Investments
Wisconsin
– -$5.5K -12,200 -99%
RFO
111
RiverGlades Family Offices
Florida
– -$6K -10,900 Closed
D.E. Shaw & Co
112
D.E. Shaw & Co
New York
– -$6K -10,829 Closed
FIA
113
Foundations Investment Advisors
Arizona
– -$5K -10,226 Closed
LA
114
LVW Advisors
New York
– -$5K -10,000 Closed
US Bancorp
115
US Bancorp
Minnesota
– -$5K -10,000 Closed
Fidelity Investments
116
Fidelity Investments
Massachusetts
– -$4K -7,044 Closed
FF
117
FourThought Financial
Florida
– -$1K -3,000 Closed
TFGT
118
TS Financial Group (TSFG)
Illinois
– -$1K -2,500 Closed
IA
119
IFP Advisors
Florida
– -$1K -1,000 Closed
Carson Wealth (CWM LLC)
120
Carson Wealth (CWM LLC)
Nebraska
– +$75 +166 New
DHGWA
121
Dixon Hughes Goodman Wealth Advisors
North Carolina
– +$450 +1,000 New
FAG
122
Fortitude Advisory Group
Washington
– +$450 +1,000 New
1 2 3 4
5

ZOM Hedge Fund Activity: Q4 2021 in Review

107 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q4 2021, worth a combined $37.8M — down 39% from $61.8M a quarter earlier.

Fund positioning in ZOM was balanced in Q4 2021: 20 funds opened new positions, 20 closed out, 32 added to existing stakes and 26 trimmed.

The largest buyer was State Street, adding an estimated $2.67M. The largest seller was BlackRock, cutting an estimated $2.43M.

  • 107 institutional investors held Zomedica Corp. (ZOM) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $37.8M of Zomedica Corp. stock for Q4 2021, down 39% quarter-over-quarter.
  • 20 funds opened new Zomedica Corp. positions in Q4 2021 and 20 closed out, a net change of 0 holders.
  • The largest Zomedica Corp. buyer in Q4 2021 was State Street, an estimated $2.67M added.
  • The largest Zomedica Corp. seller in Q4 2021 was BlackRock, an estimated $2.43M sold.

Based on aggregated 13F filings for Q4 2021.